Medi-Tech Insights Get in touch

Global Biologics CDMO Market Size, Share, Trends, Demand & Growth Analysis and Forecast 2024 to 2029

Request Quote Download FREE Sample
Single User

Table of Contents

  1. Introduction
    • Market Scope
      • Market Definition
      • Segments Covered
      • Regional Segmentation
    • Research Timeframe
    • Currency Considered
    • Study Limitations
    • Stakeholders
    • List of Abbreviations
    • Key Conferences and Events (2023-2024)
  2. Research Methodology
    • Secondary Research
    • Primary Research
    • Market Estimation
      • Bottom-Up Approach
      • Top-Down Approach
    • Market Forecasting
  3. Executive Summary
    • Biologics CDMO Market Snapshot (2023-2029)
    • Segment Overview
    • Regional Snapshot
    • Competitive Insights
  4. Market Overview
    • Market Dynamics
      • Drivers
        • Growing biopharmaceuticals market
        • Increasing complexity of biologics pushing pharma companies to outsource
        • Rising number of biologics in the pipeline being developed by small and virtual biotechs
        • Burgeoning ecosystem of smaller biopharma companies in China, supported by strong access to funding and favorable regulatory changes
      • Restraints
        • The cost of production of regenerative medicines represents a major hurdle on the path to commercialization
        • Reluctance to outsource know-how/IP by pharma
        • Scalability/capacity challenges due to complex nature of biologics
      • Opportunities
      • Biosimilars market expansion
      • Rapid growth in cell and gene therapies
    • Key Industry Trends
    • Value Chain Capability Assessment
    • Industry SpeaksKey Revenue Pockets
  5. Global Biologics CDMO Market - Size & Forecast (2021-2028), By Product Type
    • Introduction
    • Monoclonal Antibodies
    • Vaccines
    • Recombinant Proteins
    • Cell & Gene Therapy
    • Others
  6. Global Biologics CDMO Market - Size & Forecast (2021-2028), By Scale of Operation Type
    • Introduction
    • Pre-clinical & Clinical
    • Commercial
  7. Global Biologics CDMO Market - Size & Forecast (2021-2028), By Region
    • Introduction
    • North America Biologics CDMO Market Size & Forecast (2022-2029), By Country, USD billion
      • US
        • Market Size & Forecast, By Product Type (USD billion)
        • Market Size & Forecast, By Scale of Operation (USD billion)
      • Canada
        • Market Size & Forecast, By Product Type (USD billion)
        • Market Size & Forecast, By Scale of Operation (USD billion)
      • Europe Biologics CDMO Market Size & Forecast (2022-2029), By Country, USD billion
        • Germany
          • Market Size & Forecast, By Product Type (USD billion)
          • Market Size & Forecast, By Scale of Operation (USD billion)
        • France
          • Market Size & Forecast, By Product Type (USD billion)
          • Market Size & Forecast, By Scale of Operation (USD billion)
        • Italy
          • Market Size & Forecast, By Product Type (USD billion)
          • Market Size & Forecast, By Scale of Operation (USD billion)
        • UK
          • Market Size & Forecast, By Product Type (USD billion)
          • Market Size & Forecast, By Scale of Operation (USD billion)
        • Spain
          • Market Size & Forecast, By Product Type (USD billion)
          • Market Size & Forecast, By Scale of Operation (USD billion)
        • RoE
          • Market Size & Forecast, By Product Type (USD billion)
          • Market Size & Forecast, By Scale of Operation (USD billion)
        • Asia Pacific (APAC) Biologics CDMO Market Size & Forecast (2022-2029), By Country, USD billion
          • China
            • Market Size & Forecast, By Product Type (USD billion)
            • Market Size & Forecast, By Scale of Operation (USD billion)
          • Japan
            • Market Size & Forecast, By Product Type (USD billion)
            • Market Size & Forecast, By Scale of Operation (USD billion)
          • India
            • Market Size & Forecast, By Product Type (USD billion)
            • Market Size & Forecast, By Scale of Operation (USD billion)
          • Rest of Asia Pacific
            • Market Size & Forecast, By Product Type (USD billion)
            • Market Size & Forecast, By Scale of Operation (USD billion)
          • Latin America (LATAM) Biologics CDMO Market Size & Forecast (2022-2029), USD billion
            • Market Size & Forecast, By Product Type (USD billion)
            • Market Size & Forecast, By Scale of Operation (USD billion)
          • Middle East & Africa (MEA) Biologics CDMO Market Size & Forecast (2022-2029), USD billion
            • Market Size & Forecast, By Product Type (USD billion)
            • Market Size & Forecast, By Scale of Operation (USD billion)
  1. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Market Share Analysis (2023)
      • Specialized Vs Full-service CDMO competitive positioning matrix
    • Key Strategies Assessment, By Player (2021-2023)
      • New Product & Service Launches
      • Partnerships, Agreements, & Collaborations
      • Mergers & Acquisitions
      • Geographic Expansion
  1. Key Companies Scanned (Indicative List)
    • Lonza
    • Catalent
    • Wuxi Biologics
    • Samsung Biologics
    • Fujifilm
    • Boehringer Ingelheim
    • Fusion Pharma
    • Patheon
    • AGC Bilogics
    • Eurofins CDMO
    • Abbvie
    • Other Prominent Players

Related Reports

View All Research Reports